posted Jan 1, 2018, 3:10 AM by Scott Salisbury
Cannabidiol | | | NEWS | | | New Research Indicates Cannabidiol A Potential Schizophrenia TherapyA King's College London clinical trial involving the cannabis compound CBD has shown it may be beneficial in treating psychosis in schizophrenia. While cannabis can pose a risk to people with schizophrenia, this is thought to be primarily due to the effects tetrahydrocannabinol (THC), the psychoactive ... | | | Health officials crafting compelling cannabis message for youthResearch suggests cannabidiol could possess analgesic and anti-inflammatory properties, and is also believed to reduce anxiety and lower the incidence of seizures. While cannabidiol has grown popular among medicinal cannabis users, cannabidiol-dominant strains were not historically produced in ... | | | Scotland in line for multi-million pound boost from new cannabis industryResearchers have examined the health properties of Cannabidiol (CBD) – which is the non-psychoactive ingredient in marijuana – and ruled that there is now evidence to support claims it may help treat epilepsy and “a number of other medical conditions”. Available legally on the open market, CBD is ... | | | | | | |
|
|